⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIAF News
bioAffinity Technologies, Inc. Common Stock
bioAffinity Technologies and Pictor ®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD
businesswire.com
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
Q2 Virtual Investor Summit Presentations Now Available On Demand
accessnewswire.com
BIAF
EXOZ
ICU
SBC
IVDA
BEEM
BESS
CLPS
Q2 Investor Summit Virtual Live Wednesday June 24
accessnewswire.com
BEEM
BHST
BIAF
CLPS
EXOZ
ICU
IVDA
NNOX
PPSI
SBC
BESS
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering
prnewswire.com
BIAFW
BIAF
bioAffinity Technologies Announces Closing of $3.2 Million Offering
businesswire.com
BIAFW
BIAF